Currently, there is no cure for ECHS1 Deficiency. The families of the affected children have a mission to raise 700.000 USD. As a first step, 350.000 USD is needed to fund the preclinical research for ECHS1 Deficiency at UT Southwestern, Dallas, Texas, where scientists can focus on developing the ECHS1 Deficiency gene therapy.
After the preclinical research, another 350.000 USD is needed for the toxicology study to submit the research results for FDA approval.
As of March 2021, a total of 304.000 USD has been transferred by the families to a dedicated account at UT Southwestern Medical Center.
You can donate on the official page created by UT Southwestern: Click here